OCUGEN, INC revenue for the last year amounted to 84.54 M MXN, the most of which — 84.54 M MXN — came from its highest performing source at the moment, Novel Gene and Cell Therapies, Biologics and Vaccines, the year earlier bringing 102.52 M MXN. The greatest contribution to the revenue figure was made by United States — last year it brought OCUGEN, INC 84.54 M MXN, and the year before that — 102.52 M MXN.